HOLX - ホロジック (Hologic Inc.)

HOLXのニュース

   Illumina names Hologic CEO as chair, elects Edwards CFO to board  2023/06/02 14:32:37 Seeking Alpha
Illumina''s (ILMN) board has elected Hologic (HOLX) CEO Stephen MacMillan as its new non-executive chair and Edwards Lifesciences (EW) CFO Scott Ullem as an independent director.
   Illumina board appoints Hologic CEO as non-exec chairman  2023/06/02 11:56:28 Investing.com
https://www.investing.com/news/stock-market-news/illumina-board-appoints-hologic-ceo-as-nonexec-chairman-3097094
   Hologic receives FDA clearance for Panther Fusion to test COVID-19  2023/05/19 13:05:52 Seeking Alpha
Hologic (HOLX) said it had received U.S. FDA clearance for Panther Fusion SARS-CoV-2/Flu A/B/RSV assayThe assay detects and differentiates major respiratory viruses including…
   Hologic Granted FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay  2023/05/19 12:10:02 Investing.com
https://www.investing.com/news/assorted/hologic-granted-fda-clearance-of-panther-fusion-sarscov2flu-abrsv-assay-432SI-3086658
   iCAD, Hologic gain after update on breast screening guidelines  2023/05/09 16:13:32 Seeking Alpha
iCAD (ICAD) and Hologic (HOLX) recorded sharp gains on Tuesday after the U.S. Preventive Services Task Force proposed changes to breast cancer screening. Read more here.
   Non-Invasive Aesthetic Treatment Global Market Report 2022  2022/09/09 11:59:00 GlobeNewswire
Major players in the non-invasive aesthetic treatment market are Galderma S. A. , Allergen, Cutera Inc. , Alma Lasers, Cynosure, Solta Medical, Syneron Candela, Lumenis, Merz Pharma, Hologic Inc, Revance Therapeutics Inc. Major players in the non-invasive aesthetic treatment market are Galderma S. A. , Allergen, Cutera Inc. , Alma Lasers, Cynosure, Solta Medical, Syneron Candela, Lumenis, Merz Pharma, Hologic Inc, Revance Therapeutics Inc.
   Global Medical Imaging Market Size to Grow by USD 35.8 Billion | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends  2022/09/05 17:01:30 Benzinga
WASHINGTON, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The market is expected to grow as a result of factors such as the rising incidence of lifestyle-related diseases, the rising demand for early detection tools, technological advancements to speed up turnaround times, increased government investment & reimbursement initiatives, and the expansion of new facilities by market players in developing countries. Additionally, the emphasis on early diagnosis has increased due to the rising prevalence of chronic diseases like cardiovascular, neurologic problems, and other conditions, as well as the realignment of healthcare systems. For example, the Centers for Disease Control and Prevention (CDC) estimate that 18.2 million adults in the United States alone suffer from coronary artery disease (CAD) each year. Diagnostic imaging is the process of obtaining visual representations of a body''s interior for both diagnostic and therapeutic reasons using various imaging techniques. This covers a variety of modalities that are used to take pictures of the human body for the purpose of diagnosing and treating disorders and, as a result, is essential to improving general health.
   Hologic Stock: Underappreciated Gem; Bright Future (NASDAQ:HOLX)  2022/09/02 03:03:24 Seeking Alpha
Hologic''s business has remained strong despite a slowdown in COVID-19-related business. Read why I will be initiating a long position in HOLX stock.
   Hologic Inc. (NASDAQ: HOLX) Continues To Be Hot This Week?  2022/08/31 19:00:00 Stocks Register
Hologic Inc. (NASDAQ:HOLX) traded at $67.10 at last check on Wednesday, August 31, made an upward move of 0.15% on its previous day’s price. Looking at the stock we see that its previous close was $67.00 and the beta (5Y monthly) reads 1.09 with the day’s price range being $66.44 – $67.56. The company has … Hologic Inc. (NASDAQ: HOLX) Continues To Be Hot This Week? Read More »
   Hologic Continues To Offer Compelling Long-Term Value, Thesis Unchanged (NASDAQ:HOLX)  2022/08/29 19:14:01 Seeking Alpha
Hologic continues to display compelling long-term value with strong FCF generation and equally as high return on investment.
   Global Medical Imaging Informatics Markets, 2021-2028 - Rising Demand for AI- and Cloud-Based Platforms & Technological Advancements in Medical Imaging Informatics - ResearchAndMarkets.com  2022/08/01 09:06:00 Kwhen Finance
   Hologic''s Return On Capital Employed Overview  2022/07/28 15:47:20 Benzinga
Pulled from Benzinga Pro data, Hologic (NASDAQ: HOLX ) posted Q3 earnings of $228.40 million, an increase from Q2 of 49.88%. Sales dropped to $1.00 billion, a 30.15% decrease between quarters. Hologic earned $455.70 million, and sales totaled $1.44 billion in Q2. Why Is ROCE Significant? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a … Full story available on Benzinga.com
   Hologic, Inc. (HOLX) CEO Stephen MacMillan on Q3 2022 Results - Earnings Call Transcript  2022/07/28 03:23:04 Seeking Alpha
Hologic, Inc. (NASDAQ:NASDAQ:HOLX) Q3 2022 Results Earnings Conference Call July 28, 2022, 04:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan…
   Hologic (HOLX) Q3 2022 Earnings Call Transcript  2022/07/28 01:30:18 The Motley Fool
HOLX earnings call for the period ending June 30, 2022.
   Hologic Inc Q3 Profit Decreases, but beats estimates  2022/07/27 22:04:00 Finanz Nachrichten
BEDFORD (dpa-AFX) - Hologic Inc (HOLX) reported earnings for third quarter that decreased from the same period last year but beat the Street estimates.The company''s bottom line totaled $228.4 mill…

calendar